Editas Medicine, Inc.

NASDAQ:EDIT

Biotechnology

Healthcare
$1.83 +2.65%

+$0.07 today

Market cap
$281.67M
Beta
2.10
P/E (TTM)
-2.4
EPS (TTM)
-$1.11
52W Low $1.66High $4.54

Volume 2.02M

Average 2.06M

Income Statement

Follow revenue through to earnings.

Revenue

$40.52M

FY 2025 · Annual

+25.4% YoY

Operating Income

-$99.34M

FY 2025 · Annual

Net Income

-$160.06M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue25.54M19.71M78.12M32.31M40.52M
Cost of Revenue5.05M6.34M6.06M199.25M0
Gross Profit20.49M13.38M72.06M(166.93M)40.52M
Gross Margin80.2%67.9%92.2%-516.6%100.0%
Research & Development142.51M174.96M177.65M199.25M89.95M
Selling, General & Admin76.18M70.7M69.65M71.99M49.9M
Operating Expenses213.64M239.33M241.24M84.22M139.86M
Depreciation & Amortization5.05M6.34M6.06M5.81M5.28M
EBITDA(187.45M)(214.1M)(147.16M)(233.11M)(148.61M)
EBITDA Margin-733.8%-1086.1%-188.4%-721.4%-366.8%
Operating Income(193.15M)(225.95M)(169.18M)(251.15M)(99.34M)
Operating Margin-756.1%-1146.3%-216.6%-777.2%-245.2%
Interest Income607K5.52M17.57M14.06M8.31M
Interest Expense00006.17M
Other Income / Expenses644K5.52M15.96M14.06M(60.72M)
Income Before Tax(192.5M)(220.43M)(153.22M)(237.09M)(160.06M)
Pre-Tax Margin-753.6%-1118.3%-196.1%-733.7%-395.0%
Income Tax Expense00000
Net Income(192.5M)(220.43M)(153.22M)(237.09M)(160.06M)
Net Margin-753.6%-1118.3%-196.1%-733.7%-395.0%
EPS (Basic)(2.85)(3.21)(2.02)(2.88)(1.80)
EPS (Diluted)(2.85)(3.21)(2.02)(2.88)(1.80)
Weighted Avg Shares67.62M68.66M75.97M82.34M88.75M
Weighted Avg Shares (Diluted)67.62M68.66M75.97M82.34M88.75M

EDIT Earnings Waterfall · TTM

NASDAQ:EDIT · Revenue to Net Income

Key Ratios

EPS$-1.23
Gross Margin-82.9%
Net Margin-681.5%
P/E Ratio-3.6
P/S Ratio46.5

Analysis

$38.7M of revenue converted into -$109.0M of net income for the selected period. Gross margin is -82.9% and net margin is -681.5%, showing how much revenue survives after costs and taxes. EPS is $-1.23, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
4Statement of changes in beneficial ownershipNov 13, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
4Statement of changes in beneficial ownershipNov 6, 2026

How much revenue does EDIT generate?

Editas Medicine, Inc. (EDIT) reported $40.52M of revenue in fiscal 2025.

Is EDIT profitable?

Editas Medicine, Inc. (EDIT) reported -$160.06M of net income, with a net margin of -395.0%.